UNSPSC 51241221: Crystallized trypsin

This classification denotes a dermatologic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GV54A213NN. European Medicines Agency schedules crystallized trypsin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12616MIG.

UNSPSC 51241221 Crystallized trypsin, a Commodity code, shows limited recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities posted under this code do not reflect purchases of crystallized trypsin or related enzyme products; instead, they document the City of Austin's solicitation for liquid aluminum sulfate (alum) for wastewater treatment and the City of Tampa Fire Rescue's procurement of medical aid supplies. The mismatch between the code's stated product and the actual work being bought suggests either miscoding by the issuing bodies or that crystallized trypsin procurement, if it occurs in state and local markets, is not currently visible in recent solicitation records.

No representative opportunities for crystallized trypsin procurement were identified in the recent state and local contract opportunities block. The two posted solicitations — Austin's IFB 2200 CSH1061 for liquid aluminum sulfate (due August 25, 2026) and Tampa's ITB 25-P-00157 for medical aid supplies (due April 9, 2025) — fall outside the nominal scope of enzyme products. Without recent, properly coded solicitations, the geographic spread, issuing-body concentration, and market activity for crystallized trypsin at the state and local level cannot be meaningfully characterized from available data. Organizations pursuing this code should verify current classification practices with procurement offices or monitor emerging opportunities in laboratory, pharmaceutical, or healthcare settings where such enzymes would typically be specified.